Figure 9
From: A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers
Cytotoxicity evaluation—trough the MTT test—on Balb/c 3T3 fibroblasts treated for 24 h with TTC in solution (free TTC) or encapsulated in the nanoformulations (CP-DK/TTC, MM-DK/TTC), and their controls (CP-DK, MM-DK), n = 3.
